City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...

The likelihood of achieving target T-scores at the total hip and lumbar spine with denosumab depends on baseline BMD in postmenopausal women with osteoporosis.

While increased average life expectancy is a testament to modern medicine and public health efforts, an aging population ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is ...

People with the bone disease osteoporosis who break their femoral neck bones die about as often as people with malignant cancer. One doctor warns of ...

in postmenopausal women with osteoporosis. The study included 2 treatment periods. During the first period, study participants (N=479) were randomly assigned 1:1 to receive denosumab-bmwo or the ...

A well-balanced diet rich in specific nutrients is one of the most effective ways to prevent or slow bone loss related to postmenopausal osteoporosis. After menopause, you’ll experience a ...

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

Background: Osteoporosis is a serious health issue that can lead to severe clinical diseases, involving fractures. The ...